Endostatin induces autophagy in endothelial cells by modulating Beclin 1 and beta-catenin levels

Tri Minh Bui Nguyen1, Indira V Subramanian, Xue Xiao

  • 1Department of Pharmacology, University of Minnesota, Minneapolis, MN 55455, USA.

Insights

Endostatin, an angiogenesis inhibitor, triggers autophagy in endothelial cells. Inhibiting autophagy enhances endostatin

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Endostatin is a known endogenous inhibitor of angiogenesis, impacting cell proliferation and migration.
  • It functions by inhibiting integrin and Wnt-mediated signaling pathways.
  • The role of autophagy, a cellular degradation process, in response to endostatin is not fully understood.

Purpose of the Study:

  • To investigate the signaling pathways involved in autophagy activation in endothelial cells treated with endostatin.
  • To determine the role of autophagy as a survival or death mechanism in response to endostatin.
  • To explore the potential of modulating autophagy to enhance anti-angiogenic therapies.

Main Methods:

  • Treatment of endothelial cells with native and P125A-mutant endostatin.
  • Analysis of autophagy-related proteins (Beclin 1, Bcl-2, Bcl-x(L)) and beta-catenin levels.
  • Assessment of protein complex formation using co-immunoprecipitation.
  • RNA interference (RNAi) to knock down Beclin 1 expression.
  • Measurement of caspase activation to indicate apoptosis.

Main Results:

  • Endostatin treatment induced autophagy in endothelial cells, evidenced by increased Beclin 1 levels.
  • Endostatin reduced Bcl-2, Bcl-x(L), and beta-catenin, with Bcl-2 and Bcl-x(L) forming complexes with Beclin 1.
  • Restoration of beta-catenin and Wnt signaling inhibited autophagy and protected cells.
  • Beclin 1 knockdown accelerated caspase activation, indicating apoptosis.

Conclusions:

  • Endothelial cells activate autophagy as a survival response to endostatin-induced anti-angiogenic stress.
  • The Beclin 1-Bcl-2/Bcl-x(L) interaction is critical in mediating endostatin-induced autophagy.
  • Interfering with autophagy can potentiate endostatin's anti-cancer effects by promoting apoptosis.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...